nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—Triamcinolone—multiple sclerosis	0.179	0.361	CbGbCtD
Mefenamic acid—PTGS2—Betamethasone—multiple sclerosis	0.154	0.31	CbGbCtD
Mefenamic acid—PTGS2—Dexamethasone—multiple sclerosis	0.0896	0.18	CbGbCtD
Mefenamic acid—CYP2C8—Dexamethasone—multiple sclerosis	0.0436	0.0878	CbGbCtD
Mefenamic acid—CYP2C9—Dexamethasone—multiple sclerosis	0.0304	0.0613	CbGbCtD
Mefenamic acid—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00145	0.159	CbGdCrCtD
Mefenamic acid—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00142	0.156	CbGdCrCtD
Mefenamic acid—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00142	0.156	CbGdCrCtD
Mefenamic acid—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00139	0.153	CbGdCrCtD
Mefenamic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000873	0.0958	CbGdCrCtD
Mefenamic acid—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00086	0.0943	CbGdCrCtD
Mefenamic acid—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00086	0.0943	CbGdCrCtD
Mefenamic acid—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00084	0.0921	CbGdCrCtD
Mefenamic acid—Fenoprofen—ALB—multiple sclerosis	0.000411	0.219	CrCbGaD
Mefenamic acid—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000372	0.000958	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ALB—multiple sclerosis	0.000371	0.198	CrCbGaD
Mefenamic acid—Shock—Prednisolone—multiple sclerosis	0.00037	0.000954	CcSEcCtD
Mefenamic acid—Convulsion—Triamcinolone—multiple sclerosis	0.000367	0.000946	CcSEcCtD
Mefenamic acid—Tachycardia—Prednisolone—multiple sclerosis	0.000367	0.000946	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000366	0.000945	CcSEcCtD
Mefenamic acid—Convulsion—Methylprednisolone—multiple sclerosis	0.000366	0.000944	CcSEcCtD
Mefenamic acid—Hypertension—Triamcinolone—multiple sclerosis	0.000366	0.000943	CcSEcCtD
Mefenamic acid—Hypertension—Methylprednisolone—multiple sclerosis	0.000365	0.000941	CcSEcCtD
Mefenamic acid—Urticaria—Mitoxantrone—multiple sclerosis	0.000364	0.000939	CcSEcCtD
Mefenamic acid—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000362	0.000934	CcSEcCtD
Mefenamic acid—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000362	0.000934	CcSEcCtD
Mefenamic acid—Vomiting—Azathioprine—multiple sclerosis	0.00036	0.000929	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—multiple sclerosis	0.00036	0.000928	CcSEcCtD
Mefenamic acid—Anxiety—Methylprednisolone—multiple sclerosis	0.000359	0.000925	CcSEcCtD
Mefenamic acid—Drowsiness—Methotrexate—multiple sclerosis	0.000358	0.000923	CcSEcCtD
Mefenamic acid—Rash—Azathioprine—multiple sclerosis	0.000357	0.000922	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000357	0.000921	CcSEcCtD
Mefenamic acid—Dermatitis—Azathioprine—multiple sclerosis	0.000357	0.000921	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000357	0.00092	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000357	0.00092	CcSEcCtD
Mefenamic acid—Discomfort—Triamcinolone—multiple sclerosis	0.000356	0.000919	CcSEcCtD
Mefenamic acid—Discomfort—Methylprednisolone—multiple sclerosis	0.000356	0.000917	CcSEcCtD
Mefenamic acid—Headache—Azathioprine—multiple sclerosis	0.000355	0.000916	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000355	0.000915	CcSEcCtD
Mefenamic acid—Dry mouth—Triamcinolone—multiple sclerosis	0.000353	0.000909	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—multiple sclerosis	0.000352	0.000907	CcSEcCtD
Mefenamic acid—Angioedema—Betamethasone—multiple sclerosis	0.000351	0.000906	CcSEcCtD
Mefenamic acid—Angioedema—Dexamethasone—multiple sclerosis	0.000351	0.000906	CcSEcCtD
Mefenamic acid—Stomatitis—Methotrexate—multiple sclerosis	0.000349	0.0009	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—multiple sclerosis	0.000348	0.000897	CcSEcCtD
Mefenamic acid—Confusional state—Methylprednisolone—multiple sclerosis	0.000348	0.000897	CcSEcCtD
Mefenamic acid—Malaise—Dexamethasone—multiple sclerosis	0.000347	0.000894	CcSEcCtD
Mefenamic acid—Malaise—Betamethasone—multiple sclerosis	0.000347	0.000894	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000346	0.000891	CcSEcCtD
Mefenamic acid—Oedema—Triamcinolone—multiple sclerosis	0.000346	0.000891	CcSEcCtD
Mefenamic acid—Vertigo—Dexamethasone—multiple sclerosis	0.000345	0.00089	CcSEcCtD
Mefenamic acid—Vertigo—Betamethasone—multiple sclerosis	0.000345	0.00089	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000345	0.000889	CcSEcCtD
Mefenamic acid—Syncope—Dexamethasone—multiple sclerosis	0.000345	0.000889	CcSEcCtD
Mefenamic acid—Syncope—Betamethasone—multiple sclerosis	0.000345	0.000889	CcSEcCtD
Mefenamic acid—Arrhythmia—Prednisone—multiple sclerosis	0.000344	0.000886	CcSEcCtD
Mefenamic acid—Infection—Triamcinolone—multiple sclerosis	0.000343	0.000886	CcSEcCtD
Mefenamic acid—Infection—Methylprednisolone—multiple sclerosis	0.000343	0.000884	CcSEcCtD
Mefenamic acid—Haematuria—Methotrexate—multiple sclerosis	0.000341	0.00088	CcSEcCtD
Mefenamic acid—Shock—Triamcinolone—multiple sclerosis	0.00034	0.000877	CcSEcCtD
Mefenamic acid—Insomnia—Prednisolone—multiple sclerosis	0.00034	0.000877	CcSEcCtD
Mefenamic acid—Alopecia—Prednisone—multiple sclerosis	0.00034	0.000876	CcSEcCtD
Mefenamic acid—Shock—Methylprednisolone—multiple sclerosis	0.000339	0.000875	CcSEcCtD
Mefenamic acid—Loss of consciousness—Betamethasone—multiple sclerosis	0.000338	0.000871	CcSEcCtD
Mefenamic acid—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000338	0.000871	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisolone—multiple sclerosis	0.000338	0.00087	CcSEcCtD
Mefenamic acid—Tachycardia—Triamcinolone—multiple sclerosis	0.000337	0.00087	CcSEcCtD
Mefenamic acid—Mental disorder—Prednisone—multiple sclerosis	0.000337	0.000869	CcSEcCtD
Mefenamic acid—Nausea—Azathioprine—multiple sclerosis	0.000337	0.000868	CcSEcCtD
Mefenamic acid—Tachycardia—Methylprednisolone—multiple sclerosis	0.000337	0.000868	CcSEcCtD
Mefenamic acid—Skin disorder—Methylprednisolone—multiple sclerosis	0.000335	0.000864	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—multiple sclerosis	0.000334	0.000861	CcSEcCtD
Mefenamic acid—Convulsion—Dexamethasone—multiple sclerosis	0.000333	0.000859	CcSEcCtD
Mefenamic acid—Convulsion—Betamethasone—multiple sclerosis	0.000333	0.000859	CcSEcCtD
Mefenamic acid—Hypertension—Betamethasone—multiple sclerosis	0.000332	0.000856	CcSEcCtD
Mefenamic acid—Hypertension—Dexamethasone—multiple sclerosis	0.000332	0.000856	CcSEcCtD
Mefenamic acid—Asthenia—Mitoxantrone—multiple sclerosis	0.000329	0.000848	CcSEcCtD
Mefenamic acid—Anxiety—Dexamethasone—multiple sclerosis	0.000326	0.000841	CcSEcCtD
Mefenamic acid—Anxiety—Betamethasone—multiple sclerosis	0.000326	0.000841	CcSEcCtD
Mefenamic acid—Discomfort—Betamethasone—multiple sclerosis	0.000323	0.000834	CcSEcCtD
Mefenamic acid—Discomfort—Dexamethasone—multiple sclerosis	0.000323	0.000834	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—multiple sclerosis	0.000323	0.000833	CcSEcCtD
Mefenamic acid—Hypotension—Methylprednisolone—multiple sclerosis	0.000322	0.000831	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—multiple sclerosis	0.000321	0.000829	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—multiple sclerosis	0.000321	0.000829	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000317	0.000818	CcSEcCtD
Mefenamic acid—Vision blurred—Prednisone—multiple sclerosis	0.000315	0.000813	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—multiple sclerosis	0.000315	0.000812	CcSEcCtD
Mefenamic acid—Oedema—Dexamethasone—multiple sclerosis	0.000314	0.000809	CcSEcCtD
Mefenamic acid—Oedema—Betamethasone—multiple sclerosis	0.000314	0.000809	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000314	0.000809	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000314	0.000809	CcSEcCtD
Mefenamic acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000314	0.000808	CcSEcCtD
Mefenamic acid—Insomnia—Triamcinolone—multiple sclerosis	0.000313	0.000806	CcSEcCtD
Mefenamic acid—Insomnia—Methylprednisolone—multiple sclerosis	0.000312	0.000804	CcSEcCtD
Mefenamic acid—Infection—Betamethasone—multiple sclerosis	0.000312	0.000804	CcSEcCtD
Mefenamic acid—Infection—Dexamethasone—multiple sclerosis	0.000312	0.000804	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Prednisone—multiple sclerosis	0.000311	0.000801	CcSEcCtD
Mefenamic acid—Paraesthesia—Triamcinolone—multiple sclerosis	0.00031	0.0008	CcSEcCtD
Mefenamic acid—Feeling abnormal—Prednisolone—multiple sclerosis	0.00031	0.000799	CcSEcCtD
Mefenamic acid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00031	0.000799	CcSEcCtD
Mefenamic acid—Anaemia—Prednisone—multiple sclerosis	0.000309	0.000798	CcSEcCtD
Mefenamic acid—Shock—Dexamethasone—multiple sclerosis	0.000309	0.000796	CcSEcCtD
Mefenamic acid—Shock—Betamethasone—multiple sclerosis	0.000309	0.000796	CcSEcCtD
Mefenamic acid—Dyspnoea—Triamcinolone—multiple sclerosis	0.000308	0.000795	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000307	0.000792	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000307	0.000792	CcSEcCtD
Mefenamic acid—Tachycardia—Dexamethasone—multiple sclerosis	0.000306	0.000789	CcSEcCtD
Mefenamic acid—Tachycardia—Betamethasone—multiple sclerosis	0.000306	0.000789	CcSEcCtD
Mefenamic acid—Angioedema—Prednisone—multiple sclerosis	0.000306	0.000789	CcSEcCtD
Mefenamic acid—Salicylic acid—ALB—multiple sclerosis	0.000306	0.163	CrCbGaD
Mefenamic acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000304	0.000785	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—multiple sclerosis	0.000304	0.000783	CcSEcCtD
Mefenamic acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000304	0.000783	CcSEcCtD
Mefenamic acid—Malaise—Prednisone—multiple sclerosis	0.000302	0.000778	CcSEcCtD
Mefenamic acid—Vertigo—Prednisone—multiple sclerosis	0.000301	0.000775	CcSEcCtD
Mefenamic acid—Syncope—Prednisone—multiple sclerosis	0.0003	0.000774	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—multiple sclerosis	0.0003	0.000773	CcSEcCtD
Mefenamic acid—Anorexia—Betamethasone—multiple sclerosis	0.000299	0.000771	CcSEcCtD
Mefenamic acid—Anorexia—Dexamethasone—multiple sclerosis	0.000299	0.000771	CcSEcCtD
Mefenamic acid—Urticaria—Prednisolone—multiple sclerosis	0.000299	0.00077	CcSEcCtD
Mefenamic acid—Loss of consciousness—Prednisone—multiple sclerosis	0.000294	0.000759	CcSEcCtD
Mefenamic acid—Hypotension—Betamethasone—multiple sclerosis	0.000293	0.000756	CcSEcCtD
Mefenamic acid—Hypotension—Dexamethasone—multiple sclerosis	0.000293	0.000756	CcSEcCtD
Mefenamic acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000291	0.000751	CcSEcCtD
Mefenamic acid—Convulsion—Prednisone—multiple sclerosis	0.00029	0.000748	CcSEcCtD
Mefenamic acid—Hypertension—Prednisone—multiple sclerosis	0.000289	0.000745	CcSEcCtD
Mefenamic acid—Rash—Mitoxantrone—multiple sclerosis	0.000289	0.000745	CcSEcCtD
Mefenamic acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000289	0.000744	CcSEcCtD
Mefenamic acid—Headache—Mitoxantrone—multiple sclerosis	0.000287	0.00074	CcSEcCtD
Mefenamic acid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000285	0.000735	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000284	0.000733	CcSEcCtD
Mefenamic acid—Anxiety—Prednisone—multiple sclerosis	0.000284	0.000732	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—multiple sclerosis	0.000284	0.000732	CcSEcCtD
Mefenamic acid—Insomnia—Dexamethasone—multiple sclerosis	0.000284	0.000732	CcSEcCtD
Mefenamic acid—Insomnia—Betamethasone—multiple sclerosis	0.000284	0.000732	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000283	0.00073	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000282	0.000727	CcSEcCtD
Mefenamic acid—Paraesthesia—Betamethasone—multiple sclerosis	0.000282	0.000726	CcSEcCtD
Mefenamic acid—Paraesthesia—Dexamethasone—multiple sclerosis	0.000282	0.000726	CcSEcCtD
Mefenamic acid—Discomfort—Prednisone—multiple sclerosis	0.000282	0.000726	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—multiple sclerosis	0.000282	0.000726	CcSEcCtD
Mefenamic acid—Dyspepsia—Betamethasone—multiple sclerosis	0.000276	0.000712	CcSEcCtD
Mefenamic acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.000276	0.000712	CcSEcCtD
Mefenamic acid—Urticaria—Triamcinolone—multiple sclerosis	0.000275	0.000708	CcSEcCtD
Mefenamic acid—Urticaria—Methylprednisolone—multiple sclerosis	0.000274	0.000707	CcSEcCtD
Mefenamic acid—Diclofenac—ALB—multiple sclerosis	0.000274	0.146	CrCbGaD
Mefenamic acid—Body temperature increased—Triamcinolone—multiple sclerosis	0.000273	0.000705	CcSEcCtD
Mefenamic acid—Oedema—Prednisone—multiple sclerosis	0.000273	0.000704	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Prednisone—multiple sclerosis	0.000273	0.000704	CcSEcCtD
Mefenamic acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000273	0.000703	CcSEcCtD
Mefenamic acid—Decreased appetite—Betamethasone—multiple sclerosis	0.000273	0.000703	CcSEcCtD
Mefenamic acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000273	0.000703	CcSEcCtD
Mefenamic acid—Nausea—Mitoxantrone—multiple sclerosis	0.000272	0.000702	CcSEcCtD
Mefenamic acid—Infection—Prednisone—multiple sclerosis	0.000271	0.0007	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000271	0.000698	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000271	0.000698	CcSEcCtD
Mefenamic acid—Shock—Prednisone—multiple sclerosis	0.000269	0.000693	CcSEcCtD
Mefenamic acid—Flurbiprofen—ALB—multiple sclerosis	0.000268	0.143	CrCbGaD
Mefenamic acid—Tachycardia—Prednisone—multiple sclerosis	0.000267	0.000687	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—S1PR1—multiple sclerosis	0.000266	0.00256	CbGpPWpGaD
Mefenamic acid—Skin disorder—Prednisone—multiple sclerosis	0.000265	0.000684	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—multiple sclerosis	0.000264	0.00068	CcSEcCtD
Mefenamic acid—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000262	0.00252	CbGpPWpGaD
Mefenamic acid—Anorexia—Prednisone—multiple sclerosis	0.00026	0.000671	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00026	0.000669	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—GPC5—multiple sclerosis	0.000259	0.00249	CbGpPWpGaD
Mefenamic acid—Anaemia—Methotrexate—multiple sclerosis	0.000259	0.000667	CcSEcCtD
Mefenamic acid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000259	0.000667	CcSEcCtD
Mefenamic acid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000259	0.000667	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—RRM1—multiple sclerosis	0.000257	0.00247	CbGpPWpGaD
Mefenamic acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000257	0.000661	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000257	0.000661	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—multiple sclerosis	0.000252	0.00065	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—multiple sclerosis	0.000251	0.000648	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—multiple sclerosis	0.00025	0.000646	CcSEcCtD
Mefenamic acid—Urticaria—Dexamethasone—multiple sclerosis	0.000249	0.000643	CcSEcCtD
Mefenamic acid—Urticaria—Betamethasone—multiple sclerosis	0.000249	0.000643	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—GPC5—multiple sclerosis	0.000249	0.00239	CbGpPWpGaD
Mefenamic acid—Dizziness—Prednisolone—multiple sclerosis	0.000249	0.000641	CcSEcCtD
Mefenamic acid—Asthenia—Triamcinolone—multiple sclerosis	0.000248	0.00064	CcSEcCtD
Mefenamic acid—Body temperature increased—Dexamethasone—multiple sclerosis	0.000248	0.000639	CcSEcCtD
Mefenamic acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.000248	0.000639	CcSEcCtD
Mefenamic acid—Abdominal pain—Betamethasone—multiple sclerosis	0.000248	0.000639	CcSEcCtD
Mefenamic acid—Body temperature increased—Betamethasone—multiple sclerosis	0.000248	0.000639	CcSEcCtD
Mefenamic acid—Asthenia—Methylprednisolone—multiple sclerosis	0.000248	0.000638	CcSEcCtD
Mefenamic acid—Insomnia—Prednisone—multiple sclerosis	0.000247	0.000637	CcSEcCtD
Mefenamic acid—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000246	0.00236	CbGpPWpGaD
Mefenamic acid—Paraesthesia—Prednisone—multiple sclerosis	0.000245	0.000633	CcSEcCtD
Mefenamic acid—Pruritus—Triamcinolone—multiple sclerosis	0.000245	0.000631	CcSEcCtD
Mefenamic acid—Pruritus—Methylprednisolone—multiple sclerosis	0.000244	0.000629	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000244	0.00234	CbGpPWpGaD
Mefenamic acid—Ketoprofen—ALB—multiple sclerosis	0.000242	0.13	CrCbGaD
Mefenamic acid—Convulsion—Methotrexate—multiple sclerosis	0.000242	0.000625	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—RPL5—multiple sclerosis	0.000241	0.00231	CbGpPWpGaD
Mefenamic acid—Dyspepsia—Prednisone—multiple sclerosis	0.00024	0.00062	CcSEcCtD
Mefenamic acid—Decreased appetite—Prednisone—multiple sclerosis	0.000237	0.000612	CcSEcCtD
Mefenamic acid—Rash—Prednisolone—multiple sclerosis	0.000237	0.000611	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisolone—multiple sclerosis	0.000237	0.000611	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—LINGO1—multiple sclerosis	0.000237	0.00227	CbGpPWpGaD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000237	0.00061	CcSEcCtD
Mefenamic acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000236	0.000609	CcSEcCtD
Mefenamic acid—Headache—Prednisolone—multiple sclerosis	0.000236	0.000607	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—multiple sclerosis	0.000235	0.000607	CcSEcCtD
Mefenamic acid—Constipation—Prednisone—multiple sclerosis	0.000234	0.000602	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000233	0.00224	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000232	0.00222	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000231	0.00222	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SLC11A1—multiple sclerosis	0.00023	0.00221	CbGpPWpGaD
Mefenamic acid—Confusional state—Methotrexate—multiple sclerosis	0.00023	0.000594	CcSEcCtD
Mefenamic acid—Dizziness—Triamcinolone—multiple sclerosis	0.000229	0.00059	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000228	0.000589	CcSEcCtD
Mefenamic acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000228	0.000588	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—CYP24A1—multiple sclerosis	0.000228	0.00219	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP27B1—multiple sclerosis	0.000228	0.00219	CbGpPWpGaD
Mefenamic acid—Infection—Methotrexate—multiple sclerosis	0.000227	0.000585	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—RGS1—multiple sclerosis	0.000227	0.00218	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Prednisone—multiple sclerosis	0.000225	0.00058	CcSEcCtD
Mefenamic acid—Asthenia—Betamethasone—multiple sclerosis	0.000225	0.00058	CcSEcCtD
Mefenamic acid—Asthenia—Dexamethasone—multiple sclerosis	0.000225	0.00058	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000224	0.000576	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000223	0.000576	CcSEcCtD
Mefenamic acid—Nausea—Prednisolone—multiple sclerosis	0.000223	0.000576	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000223	0.00214	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000223	0.00214	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000223	0.00214	CbGpPWpGaD
Mefenamic acid—Pruritus—Dexamethasone—multiple sclerosis	0.000222	0.000572	CcSEcCtD
Mefenamic acid—Pruritus—Betamethasone—multiple sclerosis	0.000222	0.000572	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—multiple sclerosis	0.000222	0.000572	CcSEcCtD
Mefenamic acid—Vomiting—Triamcinolone—multiple sclerosis	0.00022	0.000567	CcSEcCtD
Mefenamic acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000219	0.000566	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000218	0.0021	CbGpPWpGaD
Mefenamic acid—Rash—Triamcinolone—multiple sclerosis	0.000218	0.000562	CcSEcCtD
Mefenamic acid—Dermatitis—Triamcinolone—multiple sclerosis	0.000218	0.000562	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—multiple sclerosis	0.000218	0.000561	CcSEcCtD
Mefenamic acid—Rash—Methylprednisolone—multiple sclerosis	0.000218	0.000561	CcSEcCtD
Mefenamic acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000217	0.00056	CcSEcCtD
Mefenamic acid—Urticaria—Prednisone—multiple sclerosis	0.000217	0.00056	CcSEcCtD
Mefenamic acid—Headache—Triamcinolone—multiple sclerosis	0.000217	0.000558	CcSEcCtD
Mefenamic acid—Headache—Methylprednisolone—multiple sclerosis	0.000216	0.000557	CcSEcCtD
Mefenamic acid—Body temperature increased—Prednisone—multiple sclerosis	0.000216	0.000557	CcSEcCtD
Mefenamic acid—Abdominal pain—Prednisone—multiple sclerosis	0.000216	0.000557	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—GPR65—multiple sclerosis	0.000215	0.00206	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Betamethasone—multiple sclerosis	0.000215	0.000553	CcSEcCtD
Mefenamic acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.000215	0.000553	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—multiple sclerosis	0.000213	0.00055	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000213	0.00204	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GPC5—multiple sclerosis	0.000209	0.002	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000208	0.00199	CbGpPWpGaD
Mefenamic acid—Dizziness—Betamethasone—multiple sclerosis	0.000207	0.000535	CcSEcCtD
Mefenamic acid—Dizziness—Dexamethasone—multiple sclerosis	0.000207	0.000535	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—multiple sclerosis	0.000207	0.000532	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000206	0.00198	CbGpPWpGaD
Mefenamic acid—Nausea—Triamcinolone—multiple sclerosis	0.000205	0.00053	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—TAGAP—multiple sclerosis	0.000205	0.00197	CbGpPWpGaD
Mefenamic acid—Paraesthesia—Methotrexate—multiple sclerosis	0.000205	0.000529	CcSEcCtD
Mefenamic acid—Nausea—Methylprednisolone—multiple sclerosis	0.000205	0.000528	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—multiple sclerosis	0.000204	0.000525	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000203	0.00195	CbGpPWpGaD
Mefenamic acid—Somnolence—Methotrexate—multiple sclerosis	0.000203	0.000523	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—multiple sclerosis	0.000201	0.000518	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—BCHE—multiple sclerosis	0.000201	0.00193	CbGpPWpGaD
Mefenamic acid—Vomiting—Betamethasone—multiple sclerosis	0.000199	0.000514	CcSEcCtD
Mefenamic acid—Vomiting—Dexamethasone—multiple sclerosis	0.000199	0.000514	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000199	0.00191	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Methotrexate—multiple sclerosis	0.000198	0.000512	CcSEcCtD
Mefenamic acid—Rash—Betamethasone—multiple sclerosis	0.000198	0.00051	CcSEcCtD
Mefenamic acid—Rash—Dexamethasone—multiple sclerosis	0.000198	0.00051	CcSEcCtD
Mefenamic acid—Dermatitis—Betamethasone—multiple sclerosis	0.000198	0.00051	CcSEcCtD
Mefenamic acid—Dermatitis—Dexamethasone—multiple sclerosis	0.000198	0.00051	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000197	0.000508	CcSEcCtD
Mefenamic acid—Headache—Dexamethasone—multiple sclerosis	0.000197	0.000507	CcSEcCtD
Mefenamic acid—Headache—Betamethasone—multiple sclerosis	0.000197	0.000507	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL13—multiple sclerosis	0.000196	0.00189	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCR1—multiple sclerosis	0.000196	0.00189	CbGpPWpGaD
Mefenamic acid—Asthenia—Prednisone—multiple sclerosis	0.000196	0.000505	CcSEcCtD
Mefenamic acid—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000196	0.00188	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000194	0.00186	CbGpPWpGaD
Mefenamic acid—Pruritus—Prednisone—multiple sclerosis	0.000193	0.000498	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	0.000193	0.00185	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Methotrexate—multiple sclerosis	0.000188	0.000485	CcSEcCtD
Mefenamic acid—Diarrhoea—Prednisone—multiple sclerosis	0.000187	0.000482	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000187	0.000481	CcSEcCtD
Mefenamic acid—Nausea—Dexamethasone—multiple sclerosis	0.000186	0.00048	CcSEcCtD
Mefenamic acid—Nausea—Betamethasone—multiple sclerosis	0.000186	0.00048	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000186	0.00178	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD28—multiple sclerosis	0.000184	0.00177	CbGpPWpGaD
Mefenamic acid—Urticaria—Methotrexate—multiple sclerosis	0.000181	0.000468	CcSEcCtD
Mefenamic acid—Dizziness—Prednisone—multiple sclerosis	0.000181	0.000466	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—multiple sclerosis	0.00018	0.000465	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—multiple sclerosis	0.00018	0.000465	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—S1PR1—multiple sclerosis	0.000179	0.00172	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000177	0.0017	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000177	0.0017	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000176	0.00169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GPC5—multiple sclerosis	0.000174	0.00167	CbGpPWpGaD
Mefenamic acid—Vomiting—Prednisone—multiple sclerosis	0.000174	0.000448	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000173	0.00166	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—RRM1—multiple sclerosis	0.000173	0.00166	CbGpPWpGaD
Mefenamic acid—Rash—Prednisone—multiple sclerosis	0.000172	0.000444	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisone—multiple sclerosis	0.000172	0.000444	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000172	0.00165	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000171	0.00164	CbGpPWpGaD
Mefenamic acid—Headache—Prednisone—multiple sclerosis	0.000171	0.000441	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000168	0.00162	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000166	0.00159	CbGpPWpGaD
Mefenamic acid—Asthenia—Methotrexate—multiple sclerosis	0.000164	0.000422	CcSEcCtD
Mefenamic acid—Nausea—Prednisone—multiple sclerosis	0.000162	0.000418	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—RPL5—multiple sclerosis	0.000162	0.00155	CbGpPWpGaD
Mefenamic acid—Pruritus—Methotrexate—multiple sclerosis	0.000162	0.000417	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000162	0.00155	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.00016	0.00154	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	0.00016	0.00153	CbGpPWpGaD
Mefenamic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000159	0.00153	CbGpPWpGaD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000159	0.00152	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Methotrexate—multiple sclerosis	0.000156	0.000403	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000156	0.0015	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SLC11A1—multiple sclerosis	0.000155	0.00149	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	0.000153	0.00147	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RGS1—multiple sclerosis	0.000152	0.00146	CbGpPWpGaD
Mefenamic acid—Dizziness—Methotrexate—multiple sclerosis	0.000151	0.000389	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.00015	0.00144	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	0.000148	0.00142	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—BCHE—multiple sclerosis	0.000148	0.00142	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000147	0.00142	CbGpPWpGaD
Mefenamic acid—Vomiting—Methotrexate—multiple sclerosis	0.000145	0.000374	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—GPR65—multiple sclerosis	0.000144	0.00139	CbGpPWpGaD
Mefenamic acid—Rash—Methotrexate—multiple sclerosis	0.000144	0.000371	CcSEcCtD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000144	0.00138	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000144	0.00138	CbGpPWpGaD
Mefenamic acid—Dermatitis—Methotrexate—multiple sclerosis	0.000144	0.000371	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—multiple sclerosis	0.000143	0.000369	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000141	0.00136	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SRM—multiple sclerosis	0.000141	0.00135	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCL3—multiple sclerosis	0.00014	0.00134	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	0.000137	0.00132	CbGpPWpGaD
Mefenamic acid—Nausea—Methotrexate—multiple sclerosis	0.000136	0.00035	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—PTGER4—multiple sclerosis	0.000135	0.00129	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000134	0.00129	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PGR—multiple sclerosis	0.000133	0.00127	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL13—multiple sclerosis	0.000132	0.00127	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCR1—multiple sclerosis	0.000132	0.00127	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000131	0.00126	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD86—multiple sclerosis	0.000131	0.00126	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—POMC—multiple sclerosis	0.000131	0.00125	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCR3—multiple sclerosis	0.00013	0.00125	CbGpPWpGaD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000129	0.00124	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CD28—multiple sclerosis	0.000129	0.00124	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCR2—multiple sclerosis	0.000127	0.00122	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD28—multiple sclerosis	0.000124	0.00119	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—APOE—multiple sclerosis	0.000121	0.00116	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000121	0.00116	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00012	0.00115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000117	0.00113	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000117	0.00113	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CNR1—multiple sclerosis	0.000117	0.00112	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000117	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CCR5—multiple sclerosis	0.000116	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000115	0.00111	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HLA-A—multiple sclerosis	0.000113	0.00109	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SRM—multiple sclerosis	0.000112	0.00107	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	0.000106	0.00102	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—APOE—multiple sclerosis	0.000106	0.00102	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL10—multiple sclerosis	0.000105	0.00101	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000105	0.00101	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	0.000104	0.000998	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—POMC—multiple sclerosis	0.000104	0.000997	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	0.000104	0.000995	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—BCHE—multiple sclerosis	9.93e-05	0.000953	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP27B1—multiple sclerosis	9.93e-05	0.000953	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP24A1—multiple sclerosis	9.93e-05	0.000953	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	9.8e-05	0.000941	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.7e-05	0.000932	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	9.7e-05	0.000931	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD80—multiple sclerosis	9.58e-05	0.00092	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	9.54e-05	0.000916	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ALB—multiple sclerosis	9.47e-05	0.000909	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL3—multiple sclerosis	9.42e-05	0.000904	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CD86—multiple sclerosis	9.2e-05	0.000883	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SRM—multiple sclerosis	9.1e-05	0.000874	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPC5—multiple sclerosis	9.08e-05	0.000872	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTGER4—multiple sclerosis	9.06e-05	0.00087	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCL5—multiple sclerosis	9.05e-05	0.000869	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PGR—multiple sclerosis	8.93e-05	0.000857	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—APOE—multiple sclerosis	8.87e-05	0.000852	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD86—multiple sclerosis	8.84e-05	0.000849	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCR3—multiple sclerosis	8.75e-05	0.000841	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CD28—multiple sclerosis	8.67e-05	0.000833	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—GPC5—multiple sclerosis	8.6e-05	0.000826	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCR2—multiple sclerosis	8.52e-05	0.000818	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—POMC—multiple sclerosis	8.43e-05	0.00081	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SPP1—multiple sclerosis	8.38e-05	0.000805	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCR5—multiple sclerosis	8.16e-05	0.000783	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	8.1e-05	0.000778	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TYK2—multiple sclerosis	8.09e-05	0.000777	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	8.08e-05	0.000776	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2RA—multiple sclerosis	8.04e-05	0.000772	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	7.92e-05	0.000761	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP27B1—multiple sclerosis	7.88e-05	0.000757	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP24A1—multiple sclerosis	7.88e-05	0.000757	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CNR1—multiple sclerosis	7.86e-05	0.000755	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CCR5—multiple sclerosis	7.84e-05	0.000753	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.7e-05	0.000739	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	7.7e-05	0.000739	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HLA-A—multiple sclerosis	7.64e-05	0.000733	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—POMC—multiple sclerosis	7.62e-05	0.000732	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	7.54e-05	0.000724	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—RRM1—multiple sclerosis	7.52e-05	0.000722	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APOE—multiple sclerosis	7.42e-05	0.000712	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SRM—multiple sclerosis	7.41e-05	0.000711	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD4—multiple sclerosis	7.31e-05	0.000702	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPC5—multiple sclerosis	7.21e-05	0.000692	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APOE—multiple sclerosis	7.13e-05	0.000685	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL10—multiple sclerosis	7.08e-05	0.00068	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ALB—multiple sclerosis	6.95e-05	0.000667	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.86e-05	0.000659	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CD80—multiple sclerosis	6.71e-05	0.000644	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD80—multiple sclerosis	6.45e-05	0.000619	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	6.41e-05	0.000616	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	6.41e-05	0.000616	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—POMC—multiple sclerosis	6.37e-05	0.000612	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.27e-05	0.000602	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCL2—multiple sclerosis	6.24e-05	0.000599	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CD86—multiple sclerosis	6.19e-05	0.000594	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL5—multiple sclerosis	6.09e-05	0.000585	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	6.09e-05	0.000585	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RRM1—multiple sclerosis	5.97e-05	0.000573	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—APOE—multiple sclerosis	5.97e-05	0.000573	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPC5—multiple sclerosis	5.86e-05	0.000563	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.84e-05	0.00056	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TYK2—multiple sclerosis	5.66e-05	0.000544	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—multiple sclerosis	5.66e-05	0.000544	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SPP1—multiple sclerosis	5.64e-05	0.000542	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPL5—multiple sclerosis	5.6e-05	0.000537	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.51e-05	0.000529	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.5e-05	0.000528	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCR5—multiple sclerosis	5.49e-05	0.000527	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TYK2—multiple sclerosis	5.44e-05	0.000523	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2RA—multiple sclerosis	5.41e-05	0.000519	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.39e-05	0.000518	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC11A1—multiple sclerosis	5.36e-05	0.000515	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—multiple sclerosis	5.26e-05	0.000505	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—multiple sclerosis	5.25e-05	0.000504	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.22e-05	0.000501	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.22e-05	0.000501	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK1—multiple sclerosis	5.15e-05	0.000494	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.13e-05	0.000493	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—POMC—multiple sclerosis	5.13e-05	0.000493	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.1e-05	0.00049	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.01e-05	0.000481	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—multiple sclerosis	4.99e-05	0.000479	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD4—multiple sclerosis	4.92e-05	0.000473	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RRM1—multiple sclerosis	4.86e-05	0.000467	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.77e-05	0.000458	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—multiple sclerosis	4.71e-05	0.000452	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—multiple sclerosis	4.68e-05	0.000449	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.63e-05	0.000445	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.57e-05	0.000439	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CD80—multiple sclerosis	4.51e-05	0.000433	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—multiple sclerosis	4.46e-05	0.000428	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—BCHE—multiple sclerosis	4.32e-05	0.000415	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—POMC—multiple sclerosis	4.29e-05	0.000412	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD28—multiple sclerosis	4.28e-05	0.000411	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL2—multiple sclerosis	4.2e-05	0.000403	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.98e-05	0.000382	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—multiple sclerosis	3.97e-05	0.000381	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—multiple sclerosis	3.96e-05	0.00038	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.95e-05	0.00038	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TYK2—multiple sclerosis	3.81e-05	0.000366	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—multiple sclerosis	3.81e-05	0.000366	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.77e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—multiple sclerosis	3.68e-05	0.000354	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—multiple sclerosis	3.68e-05	0.000353	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.63e-05	0.000348	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK1—multiple sclerosis	3.6e-05	0.000346	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—multiple sclerosis	3.54e-05	0.00034	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—multiple sclerosis	3.53e-05	0.000339	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK1—multiple sclerosis	3.46e-05	0.000333	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BCHE—multiple sclerosis	3.43e-05	0.000329	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.24e-05	0.000311	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—multiple sclerosis	3.17e-05	0.000304	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.07e-05	0.000295	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD86—multiple sclerosis	3.05e-05	0.000293	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—multiple sclerosis	3e-05	0.000288	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.95e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.000268	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—multiple sclerosis	2.77e-05	0.000266	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CCR5—multiple sclerosis	2.71e-05	0.00026	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—multiple sclerosis	2.67e-05	0.000256	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—multiple sclerosis	2.66e-05	0.000256	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HLA-A—multiple sclerosis	2.64e-05	0.000253	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.64e-05	0.000253	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—multiple sclerosis	2.6e-05	0.00025	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—multiple sclerosis	2.48e-05	0.000238	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—multiple sclerosis	2.47e-05	0.000238	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—multiple sclerosis	2.46e-05	0.000237	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK1—multiple sclerosis	2.43e-05	0.000233	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.4e-05	0.000231	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.27e-05	0.000218	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—POMC—multiple sclerosis	2.23e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD80—multiple sclerosis	2.23e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—multiple sclerosis	2.06e-05	0.000198	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—multiple sclerosis	2.04e-05	0.000195	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TYK2—multiple sclerosis	1.88e-05	0.000181	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—multiple sclerosis	1.86e-05	0.000179	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—POMC—multiple sclerosis	1.77e-05	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD4—multiple sclerosis	1.7e-05	0.000163	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—multiple sclerosis	1.62e-05	0.000155	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—POMC—multiple sclerosis	1.44e-05	0.000138	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000131	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—multiple sclerosis	1.32e-05	0.000126	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—multiple sclerosis	1.31e-05	0.000126	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—multiple sclerosis	1.22e-05	0.000117	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—multiple sclerosis	1.22e-05	0.000117	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK1—multiple sclerosis	1.2e-05	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—POMC—multiple sclerosis	1.17e-05	0.000113	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—multiple sclerosis	1.07e-05	0.000103	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—multiple sclerosis	9.2e-06	8.83e-05	CbGpPWpGaD
